Abstract
The purpose of this review was to assess the prevalence of asthenic syndrome (AS) in patients infected with SARS-CoV‑2, and to determine the effect of AS on the process of convalescence and the course of comorbid diseases.Main provisions. AS is one of the most common manifestations after a COVID infection of varying severity, which in neurological patients can aggravate the course of the underlying disease and reduce the effectiveness of rehabilitation measures. Timely diagnosis allows you to identify AS and correct it with the use of medication and non-drug methods.Conclusion. Due to the limited number of studies concerning AS in COVID‑19, it is necessary to further study the clinical features of this disease, to develop algorithms for medical rehabilitation, taking into account the clinical polymorphism of AS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
